StockData
EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

EyePoint, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$0.44−2.55 (-85.28%)

Close on Oct 19, 2026

Market cap
$38.08K
P/E (TTM)
–
Dividend yield
–

EyePoint, Inc. revenue by segment

By business segment

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016FY2015% of revenueYoY
License and Collaboration Agreements [Member]$16.73M$38.50M$30.80M$362.00K$756.00K$11.94M$1.34M$6.57M––53.3%-56.5%
Royalty Income [Member]$13.04M$1.61M$989.00K$1.14M$871.00K$1.66M$1.62M$970.00K$1.22M–41.6%+708.5%
YUTIQ [Member]$1.60M$3.10M$14.20M$28.33M$16.96M$13.88M––––5.1%-48.4%
Product [Member]$1.60M$3.16M$14.23M$39.91M$35.31M$20.83M$0$0––5.1%-49.6%
Collaborative Research and Development [Member]–––$0$60.00K$255.00K$1.34M$6.57M$398.00K–––
DEXYCU [Member]––$0$11.58M$18.35M$6.95M––––––

By region

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016FY2015% of revenueYoY
United States$29.98M$42.05M$45.27M$40.48M$35.99M$22.62M$2.86M$7.44M$1.52M$26.47M95.6%-28.7%
China$1.29M$1.12M$648.00K$823.00K$851.00K$11.71M––––4.1%+14.9%
United Kingdom$100.00K$100.00K$100.00K$100.00K$100.00K$100.00K$100.00K$100.00K$100.00K$100.00K0.3%0.0%

From the segment and revenue-disaggregation notes of EyePoint's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.